Canadian Cancer Trials Group Bulletins

Trial Management Group


Permanent Trial Closure

CE.6 - A Randomized Phase III Study of Temozolomide and Short-Course Radiation vs. Short-Course Radiation Alone in the Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients - has been permanently closed.

The notification to sites can be found under the "CCTG Toolbox" here: https://www.ctg.queensu.ca/trials/permanent_closure/permanent-trial-closure/.